Friday, July 4, 2025 7/4/2025

Evaluation of Euterpe oleracea Mart. (açaí) for inhibition of UGTs as a mechanism of botanical-drug interactions involving anticancer drugs

Award Number: F31AT012266
ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 01/03/2023
PERIOD OF PERFORMANCE END DATE: 05/02/2024

Group Awards By:

View Award Description

Evaluation of Euterpe oleracea Mart. (açaí) for inhibition of UGTs as a mechanism of botanical-drug interactions involving anticancer drugs - PROJECT SUMMARY Studies have shown that up to 80% of cancer patients reported using botanical dietary supplements (BDS) following their initial cancer diagnoses. BDS have been found to be consumed more by cancer patients than otherwise healthier patients without cancer to alleviate side effects of chemotherapy drugs and/or increase quality of life. Upon examination of the U.S. Food and Drug Administration Adverse Event Reporting System database, our research team found an indicated potential risk between CYP3A4 non-interactive anticancer drugs and BDS containing Euterpe oleracea Mart. (açaí), which included an increased risk for cardiovascular adverse events when taken together. However, the mechanism of this interaction remains unknown. The popularity of açaí containing products continues to grow and, now in 2022, açaí is among the top 40 botanicals used in the United States. Based on a cross-examination of the literature, we hypothesize that hepatic UDP- glucuronosyltransferases (UGTs) are the target in which inhibition by compounds in açaí could promote cardiovascular adverse events when taken with anticancer drugs. This proposal will identify extracts of açaí containing UGT inhibitors and test our newly automated Global Natural Product Social Molecular Networking (GNPS) coupled to Bioactivity tool for elucidation of inhibitory compounds. Specific Aim 1A: Generate UGT inhibition assays to elucidate the potential for chemical constituents in açaí extract for inhibition of UGT enzymes. Extracts will be tested for inhibition of UGT isoforms 1A1, 1A3, 1A4, 1A6, 1A9, and 2B7 using recombinant human UGTs generated from baculovirus-transfected insect cells. Specific Aim 1B: LC-MS/MS chemical fingerprints of açaí extracts will be used to form Bioactive Molecular Networks (BMN) using our automated GNPS-Bioactivity dashboard to predict inhibitors of UGTs. Commercially available compounds predicted from this tool will be purchased and verified before testing in isolation for UGT inhibition. The result of this project will be a potential mechanism by which constituents of BDS containing açaí are causing BDS-anticancer drug interactions that are clinically relevant for the treatment of cancer.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$1,945 )
2025	2024	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	000	2	3/25/2025	NON-COMPETING CONTINUATION	-$1,945
														Subtotal = -$1,945

Issue Date FY: 2024 ( Subtotal = $16,299 )
2024	2024	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	002	2	5/23/2024	NON-COMPETING CONTINUATION	-$14,135
2024	2024	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	000	2	12/8/2023	NON-COMPETING CONTINUATION	$29,424
2024	2024	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	001	2	5/2/2024	NON-COMPETING CONTINUATION	$1,010
														Subtotal = $16,299

Issue Date FY: 2023 ( Subtotal = $38,553 )
2023	2023	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	002	1	6/16/2023	NEW	$942
2023	2023	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	001	1	1/9/2023	NEW	$0
2023	2023	AUBURN UNIVERSITY	321-A INGRAM HALL	AUBURN	AL	36849	LEE	USA	Research and Training in Complementary and Integrative Health	000	1	12/30/2022	NEW	$37,611
														Subtotal = $38,553

Grand Total All Awards = $52,907

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Evaluation of Euterpe oleracea Mart. (açaí) for inhibition of UGTs as a mechanism of botanical-drug interactions involving anticancer drugs

Award Number: F31AT012266

ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 01/03/2023

PERIOD OF PERFORMANCE END DATE: 05/02/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer